While there is some evidence suggesting that HER receptor signaling may influence ferroptosis in other cancer types, such as breast cancer [21] or melanoma [22], no studies to date have explored the potential link between ERBB3 and ferroptosis in gastric cancer. Here, ERBB3 is linked to breast cancer.